Table.
Clinical Profile of nAMD and ARC Patients Participating in the Study was Shown
| nAMD Patients | ARC Patients | P Value | |
|---|---|---|---|
| Eyes, n | 10 | 10 | — |
| Age, years | 77.2 ± 3.8 | 78.4 ± 3.2 | 0.642 |
| Females/males | 5/5 | 6/4 | 0.548 |
| logMAR visual acuity | 0.41 ± 0.17 | 0.27 ± 0.13 | 0.546 |
| Systemic diseases, n(%) | |||
| Hypertension | 4 (40) | 5 (50) | 0.548 |
| Diabetes | 2 (20) | 3 (30) | 0.334 |
| Hyperlipidemia | 4 (40) | 3 (30) | 0.398 |
| Coronary heart disease | 1 (10) | 2 (20) | 0.232 |
| Renal disease | 0 | 0 | — |
| Liver disease | 0 | 0 | — |
| Cerebrovascular disease | 2 (20) | 1 (10) | 0.232 |
| Alcohol intake | 4 (40) | 3 (30) | 0.398 |
| Smoking | 2 (20) | 4 (40) | 0.081 |
| Ocular diseases, n (%) | |||
| Polypoidal choroidal vasculopathy | 0 | 0 | — |
| Retinal angiomatous proliferation | 0 | 0 | — |
nAMD, neovascular AMD; ARC, age-related cataract.